Beam Therapeutics NasdaqGS:BEAM Stock Report ; Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 03 Sep, From what 0 stock analysts predict, the share price for Beam Therapeutics Inc (BEAM) might increase by % in the next year. This is based on a month. Get Beam Therapeutics Inc (BEAM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Beam Therapeutics (NASDAQ:BEAM) Stock, Analyst Ratings, Price Targets, Forecasts Beam Therapeutics Inc has a consensus price target of $ based on the. The current price of BEAM is USD — it has decreased by −% in the past 24 hours. Watch Beam Therapeutics Inc. stock price performance more closely on.
Find the latest Beam Therapeutics Inc (BEAM) stock forecast, month price target, predictions and analyst recommendations. stock price prediction is 0 USD. The stock forecast is 0 USD for September 08, Monday with technical analysis. Beam Therapeutics Inc. analyst estimates, including BEAM earnings per share Stock Price Targets. High, $ Median, $ Low, $ Average, $ Beam Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BEAM updated stock price target summary. BEAM Price Targets Summary. Beam Therapeutics Inc Wall Street analysts forecast BEAM stock price to rise over the next 12 months. According to Wall Street. Stock Price Forecast. The 9 analysts with month price forecasts for Beam Therapeutics stock have an average target of , with a low estimate of 27 and a. View Beam Therapeutics, Inc. BEAM stock quote prices, financial information, real-time forecasts, and company news from CNN. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the. future price: according to them, BEAM price has a max estimate of USD and a min estimate of USD. Watch BEAM chart and read a more detailed Beam. From what 0 stock analysts predict, the share price for Beam Therapeutics Inc (BEAM) might increase by % in the next year. This is based on a month.
Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which. Trade of the Day: Buy Beam Therapeutics Call Options as BEAM Stock Heads to $ The Beam Therapeutics stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price of. BEAM's current price target is $ Learn why top analysts are making this stock forecast for Beam Therapeutics at MarketBeat. The average price target is $ with a high estimate of $80 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to. The forecasts for Beam Therapeutics Inc. (BEAM) range from a low of $23 to a high of $ The average price target represents a increase of $ from the. Beam Therapeutics started at market perform with $41 stock price target at BMO Capital. Jun. 17, at p.m. ET by Tomi Kilgore. Read full story. On average, Wall Street analysts predict that Beam Therapeutics's share price could reach $ by Aug 22, The average Beam Therapeutics stock price.
Following the upgrade, the current consensus from Beam Therapeutics' 14 analysts is for revenues of US$97m in which - if met - would reflect a substantial. What was Beam Therapeutics's price range in the past 12 months? Beam Therapeutics lowest stock price was $ and its highest was $ in the past 12 months. Beam Therapeutics Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. The stock price for Beam Therapeutics (NASDAQ: BEAM) is $ last updated September 6, at PM EDT. Q. Does Beam Therapeutics (BEAM) pay a dividend? A. The current Beam Therapeutics [BEAM] share price is $ The Score for BEAM is 57, which is 14% above its historic median score of 50, and infers lower risk.
The average one-year price target for Beam Therapeutics Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is. Beam Therapeutics Inc Price (BEAM) Daily Price Prediction Charts. View the BEAM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beam Therapeutics Inc. Beam Therapeutics's revenue and earnings are forecast to decline at % and % per annum respectively. EPS is expected to decline by % per annum. Return. Analyst. Target Price. ; Earnings. EPS Forecast. Down ; Investor. New Investor. ARK Investment Management LLC ; Financials. Valuation. High ; Insiders. Based on a normal probability distribution, the odds of Beam Therapeutics to move above the current price in 90 days from now is roughly (This Beam.
Banks That Have No Fees | Sms Code 32665